Quinacainol

This classification denotes an antiarrhythmic agent with the molecular formula C21H30N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 5OX8977NGO, chemically known as 4-quinolinemethanol, 2-(1,1-dimethylethyl)-alpha-(2-(4-piperidinyl)ethyl)- but more generally known as quinacainol, which bears US NIH Compound Identifier 55464. European Medicines Agency schedules Quinacainol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10197MIG. The term QUINACAINOL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 38, No. 6, 1984, List 24). QUINACAINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule quinacainol under HS 29334990 and SITC 51575. As of Q4 2014, QUINACAINOL remains US FDA's Preferred Term for this commodity. Quinacainol bears US NLM identifiers UMLS ID C0071172 and NCI Concept Code C82229. SMILES: OC(CCC1CCNCC1)C1CC(NC2C1CCCC2)C(C)(C)C.